Beijing Konruns Pharmaceutical Co.,Ltd. (SHA:603590)
China · Delayed Price · Currency is CNY 30.40
+0.56 (1.88%)
Aug 4, 2026, 3:00 PM CST
SHA:603590 Market Cap
SHA:603590 has a market cap or net worth of 4.7 billion as of August 4, 2026. Its market cap has decreased by -53.46% in one year.
Market Cap
4.70B
Enterprise Value
4.53B
Revenue
917.99M
Ranking
n/a
PE Ratio
28.16
Stock Price
30.40
ChartMarket Cap Chart
Since August 27, 2018, SHA:603590's market cap has decreased from 5.61B to 4.70B, a decrease of -16.18%. That is a compound annual growth rate of -2.20%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2026 | 4.70B | -25.63% |
| Dec 31, 2025 | 6.32B | 69.72% |
| Dec 31, 2024 | 3.72B | -37.51% |
| Dec 29, 2023 | 5.96B | 52.69% |
| Dec 30, 2022 | 3.90B | -23.24% |
| Dec 31, 2021 | 5.08B | -12.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hangzhou Biotest Biotech | 5.32B |
| Novogene | 5.23B |
| Suzhou Fengbei Biotech Stock | 4.84B |
| Shouyao Holdings (Beijing) Co., LTD. | 4.73B |
| Shenzhen Weiguang Biological Products | 4.58B |
| R&G PharmaStudies | 4.54B |
| ChemPartner PharmaTech | 4.54B |
| Xiangxue Pharmaceutical | 4.46B |